Philippe Reginault
9Patents
5h-index
9Co-inventors
56Inventor score
Filing activity: Mar 25, 1988 → May 10, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4895726A | Novel dosage form of fenofibrate | Human Necessities | 147 | Expired |
| US4837025A | Self-adhesive device for the percutaneous administration of an active ingredient | Human Necessities | 8 | Expired |
| US7976869B2 | Fenofibrate tablets | Human Necessities | 7 | Active |
| US5561154A | Treatment of acute urinary retention | Human Necessities | 7 | Expired |
| US4842864A | Self-adhesive device for the percutaneous administration of an active ingredient | Human Necessities | 5 | Expired |
| US5451609A | Treatment of impotence | Human Necessities | 4 | Expired |
| US8153792B2 | Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors | Human Necessities | 1 | Active |
| US8492545B2 | Aminothiazole compounds as kinase inhibitors and methods of using the same | Human Necessities | 1 | Active |
| US8940894B2 | Aminothiazole compounds as kinase inhibitors and methods of using the same | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.